Skip to main content
. Author manuscript; available in PMC: 2021 Apr 19.
Published in final edited form as: Br J Haematol. 2019 Aug 16;187(1):25–38. doi: 10.1111/bjh.16157

Figure 1. A summary of the main available sources of Treg cells and of the methods for expading them in vitro and in vivo for GvHD treatment.

Figure 1.

Ab’s: antibodies; APCs: antigen presenting cells; GvHD: graft-versus-host disease; IL-2: interleukin 2; Treg: T regulatory.

The figure was produced using Servier Medical Art (www.servier.com).